|
1.
|
Lee JH, Bae JS, Ryu KW, et al: Gastric
cancer patients at high-risk of having synchronous cancer. World J
Gastroenterol. 12:2588–2592. 2006.
|
|
2.
|
Ciccotosto GD, McLeish A, Hardy KJ and
Shulkes A: Expression, processing, and secretion of gastrin in
patients with colorectal carcinoma. Gastroenterology.
109:1142–1153. 1995.
|
|
3.
|
Hollande F, Imdahl A, Mantamadiotis T,
Ciccotosto GD, Shulkes A and Baldwin GS: Glycine-extended gastrin
acts as an autocrine growth factor in a nontransformed colon cell
line. Gastroenterology. 113:1576–1588. 1997.
|
|
4.
|
Brown D, Yallampalli U, Owlia A and Singh
P: pp60c-Src kinase mediates growth effects of the full-length
precursor progastrin1-80 peptide on rat intestinal epithelial
cells, in vitro. Endocrinology. 144:201–211. 2003.
|
|
5.
|
Koh TJ: Extragastric effects of gastrin
gene knock-out mice. Pharmacol Toxicol. 91:368–374. 2002.
|
|
6.
|
Kanno T, Matsuki T, Oka M, et al: Gastric
acid reduction leads to an alteration in lower intestinal
microflora. Biochem Biophys Res Commun. 381:666–670. 2009.
|
|
7.
|
Inoue I, Mukoubayashi C, Yoshimura N, et
al: Elevated risk of colorectal adenoma with Helicobacter
pylori-related chronic gastritis: a population-based
case-control study. Int J Cancer. 129:2704–2711. 2011.
|
|
8.
|
Saini SD, Kim HM and Schoenfeld P:
Incidence of advanced adenomas at surveillance colonoscopy in
patients with a personal history of colon adenomas: a meta-analysis
and systematic review. Gastrointest Endosc. 64:614–626. 2006.
|
|
9.
|
Lin OS: Clinical update: postpolypectomy
colonoscopy surveillance. Lancet. 370:1674–1676. 2007.
|
|
10.
|
Martinez EM, Baron AJ, Lieberman AD, et
al: A pooled analysis of advanced colorectal neoplasia diagnoses
after colonoscopic polypectomy. Gastroenterology. 136:832–841.
2009.
|
|
11.
|
Kikuchi S and Miwa H: Efficacy of the
ELISA test ‘E Plate Eiken H. pylori antibody’ for the
diagnosis of Helicobacter pylori infection. Jpn J Med Pharm
Sci. 43:581–586. 2000.(In Japanese).
|
|
12.
|
Ichinose M, Miki K, Furihata C, et al:
Radioimmunoassay of serum group I and group II pepsinogens in
normal controls and patients with various disorders. Clin Chim
Acta. 126:183–191. 1982.
|
|
13.
|
Ichinose M, Yahagi N, Oka M, Ikeda H, Miki
K and Omata M: Screening for gastric cancer in Japan. Cancer
Screening. Wu GY and Aziz K: Humana Press; Totowa, NJ: pp. 255–268.
2001
|
|
14.
|
Yanaoka K, Oka M, Mukoubayashi C, et al:
Cancer high-risk subjects identified by serum pepsinogen tests:
outcomes after 10-year follow-up in asymptomatic middle-aged males.
Cancer Epidemiol Biomarkers Prev. 17:838–845. 2008.
|
|
15.
|
Komine M: Megaloblastic anemia. Int J
Hematol. 71:82000.
|
|
16.
|
Ohata H, Kitauchi S, Yoshimura N, et al:
Progression of chronic atrophic gastritis associated with
Helicobacter pylori infection increases risk of gastric
cancer. Int J Cancer. 109:138–143. 2004.
|
|
17.
|
Takeda M, Iwachika C, Demura H, Shiratori
K and Watanabe S: Experimental and clinical investigation of
gastrin RIA kit α. Horumon To Rinsho. 31:1123–1128. 1983.(In
Japanese).
|
|
18.
|
Harewood GC and Lawlor GO: Incident rates
of colonic neoplasia according to age and gender. J Clin
Gastroenterol. 39:894–899. 2005.
|
|
19.
|
Laiyemo AO, Murphy G, Albert PS, et al:
Postpolypectomy surveillance guidelines: predictive accuracy for
advanced adenoma at 4 years. Ann Intern Med. 148:419–426. 2008.
|
|
20.
|
Boolchand V, Olds G, Singh P, Chak A and
Cooper GS: Colorectal screening after polypectomy: a national
survey study of primary care physicians. Ann Intern Med.
145:654–659. 2006.
|
|
21.
|
Correa P: Human gastric carcinogenesis: a
multistep and multi-factorial process - First American Cancer
Society Award Lecture on Cancer Epidemiology and Prevention. Cancer
Res. 52:6735–6740. 1992.
|
|
22.
|
Meucci G, Tatarella M, Vecchi M, et al:
High prevalence of Helicobacter pylori infection in patients
with colonic adenomas and carcinomas. J Clin Gastroenterol.
25:605–607. 1997.
|
|
23.
|
Breuer-Katschinski B, Nemes K, Marr A,
Rump B, Leiendecker B, Breuer N and Goebell H: Helicobacter
pylori and the risk of colonic adenomas. Colorectal Adenoma
Study Group Digestion. 60:210–215. 1999.
|
|
24.
|
Mizuno S, Morita Y, Inui T, et al:
Helicobacter pylori infection is associated with colon
adenomatous polyps detected by high-resolution colonoscopy. Int J
Cancer. 117:1058–1059. 2005.
|
|
25.
|
Fireman Z, Trost L, Kopelman Y, Segal A
and Sternberg A: Helicobacter pylori: seroprevalence and
colorectal cancer. Isr Med Assoc J. 2:6–9. 2000.
|
|
26.
|
Shmuely H, Passaro D, Figer A, et al:
Relationship between Helicobacter pylori CagA status and
colorectal cancer. Am J Gastroenterol. 96:3406–3410. 2001.
|
|
27.
|
Fujimori S, Kishida T, Kobayashi T, et al:
Helicobacter pylori infection increases the risk of
colorectal adenoma and adenocarcinoma, especially in women. J
Gastroenterol. 40:887–893. 2005.
|
|
28.
|
Jones M, Helliwell P, Pritchard C,
Tharakan J and Mathew J: Helicobacter pylori in colorectal
neoplasms: is there an aetiological relationship? World J Surg
Oncol. 5:512007.
|
|
29.
|
Machida-Montani A, Sasazuki S, Inoue M, et
al: Atrophic gastritis, Helicobacter pylori, and colorectal
cancer risk: a case-control study. Helicobacter. 12:328–332.
2007.
|
|
30.
|
Laiyemo AO, Kamanger F, Marcus PM, Taylor
PR, Virtamo J, Albanes D and Stolzenberg-Solomon RZ: Atrophic
gastritis and the risk of incident colorectal cancer. Cancer Causes
Control. 21:163–170. 2010.
|
|
31.
|
Imperiale TF, Glowinski EA, Lin-Cooper C,
Larkin GN, Rogge JD and Ransohoff DF: Five-year risk of colorectal
neoplasia after negative screening colonoscopy. N Engl J Med.
359:1218–1224. 2008.
|
|
32.
|
Georgopoulos SD, Polymeros D,
Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG and Ladas SD:
Hypergastrinemia is associated with increased risk of distal colon
adenomas. Digestion. 74:42–46. 2006.
|
|
33.
|
Penman ID, el-Omar E, Ardill JES, McGregor
JR, Galloway DJ, O’Dwyer PJ and McColl KE: Plasma gastrin
concentrations are normal in patients with colorectal neoplasia and
unaltered following tumor resection. Gastroenterology.
106:1263–1270. 1994.
|
|
34.
|
Kado S, Uchida K, Funabashi H, et al:
Intestinal microflora are necessary for development of spontaneous
adenocarcinoma of the large intestine in T-cell receptor β chain
and p53 double-knockout mice. Cancer Res. 61:2395–2398. 2001.
|
|
35.
|
Howden CW and Hunt RH: Relationship
between gastric secretion and infection. Gut. 28:96–107. 1987.
|
|
36.
|
Drasar BS, Shiner M and McLeod GM: Studies
on the intestinal flora: I. The bacterial flora of the
gastrointestinal tract in healthy and achlorhydric persons.
Gastroenterology. 56:71–79. 1969.
|
|
37.
|
Thorens J, Froehlich F, Schwizer W, et al:
Bacterial overgrowth during treatment with omeprazole compared with
cimetidine: a prospective randomized double blind study. Gut.
39:54–59. 1996.
|
|
38.
|
Evenepoel P, Claus D, Geypens B, Maes B,
Hiele M, Rutgeerts P and Ghoos Y: Evidence for impaired
assimilation and increased colonic fermentation of protein, related
to gastric acid suppression therapy. Aliment Pharmacol Ther.
12:1011–1019. 1998.
|
|
39.
|
Visek WJ: Diet and cell growth modulation
by ammonia. Am J Clin Nutr. 31:216–220. 1978.
|
|
40.
|
LeVeen HH, LeVeen EG and LeVeen RF:
Awakenings to the pathogenicity of urease and the requirement for
continuous long-term therapy. Biomed Pharmacother. 48:157–166.
1994.
|
|
41.
|
Clinton SK, Bostwick DG, Olson LM, Mangian
HJ and Visek WJ: Effects of ammonium acetate and sodium cholate on
N-methyl-N-nitro-N-nitrosoguanidine-induced colon carcinogenesis of
rats. Cancer Res. 48:3035–3039. 1988.
|
|
42.
|
Martinez ME, Sampliner R, Marshall JR,
Bhattacharyya AK, Reid ME and Alberts DS: Adenoma characteristics
as risk factors for recurrence of advanced adenomas.
Gastroenterology. 120:1077–1083. 2001.
|
|
43.
|
Iacopetta B: Are there two sides to
colorectal cancer? Int J Cancer. 101:403–408. 2002.
|
|
44.
|
Nakajima T, Enomoto S and Ushijima T: DNA
methylation: a marker for carcinogen exposure and cancer risk.
Environ Health Prev Med. 13:8–15. 2008.
|
|
45.
|
Giovannucci E, Colditz GA and Stampfer MJ:
A meta-analysis of cholecystectomy and risk of colorectal cancer.
Gastroenterology. 105:130–141. 1993.
|
|
46.
|
Pereira MA, Wang W, Kramer PM and Tao L:
DNA hypomethylation induced by non-genotoxic carcinogens in mouse
and rat colons. Cancer Lett. 212:145–151. 2004.
|
|
47.
|
Bernstein H, Bernstein C, Payne CM,
Dvorakova K and Garewal H: Bile acids as carcinogens in human
gastrointestinal cancers. Mutat Res. 589:47–65. 2005.
|
|
48.
|
Rex DK, Cutler CS, Lemmel GT, et al:
Colonoscopic miss rates of adenomas determined by back-to-back
colonoscopies. Gastroenterology. 112:24–28. 1997.
|
|
49.
|
Hixson LJ, Fennerty MB, Sampliner RE and
Garewal HS: Prospective blinded trial of the colonoscopy miss-rate
of large colorectal polyps. Gastrointest Endosc. 37:125–127.
1991.
|
|
50.
|
Robertson DJ, Greenberg ER, Beach M, et
al: Colorectal cancer in patients under close colonoscopic
surveillance. Gastroenterology. 129:34–41. 2005.
|
